YUFLYMA

ਉਤਪਾਦ ਝਲਕ

About YUFLYMA

YUFLYMA is a prescription medication containing the active ingredient Adalimumab, a recombinant human monoclonal antibody. It is used to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.

Key Benefits & Uses

• Treatment of moderate to severe rheumatoid arthritis in adults, reducing symptoms and slowing disease progression.
• Treatment of active psoriatic arthritis in adults, reducing symptoms and slowing disease progression.
• Treatment of ankylosing spondylitis in adults, reducing symptoms and slowing disease progression.
• Treatment of moderate to severe plaque psoriasis in adults, reducing symptoms and slowing disease progression.

Active Ingredient & Action

Adalimumab works by binding to tumor necrosis factor-alpha (TNF-alpha), a substance in the body that causes inflammation and is involved in autoimmune diseases. By blocking TNF-alpha, Adalimumab reduces inflammation and slows disease progression.

Important Notes

YUFLYMA is available by prescription only and should be used under the guidance of a healthcare professional. It may cause serious side effects, including increased risk of infections, allergic reactions, and cancer. Patients with a history of hepatitis B or C should be tested before starting treatment. Concomitant use with other biologic agents or live vaccines is not recommended.